chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt awoke in the middle of the night complaining of itching. Mom noted rash (dime-sized raised and red areas on legs and arms at 08:00. Into office. At 11:45, noted almost solid welted areas, reddened lower legs bilaterally with complaint of itching. Noted raised and reddened areas on right posterior arm 1" X 2 7/8" (butterfly shaped). Left posterior arm 1/2" X 1", 1 1/4" X 1 1/2", 5/8" X 1" areas connecting with irregular raised areas beneath injection site. Upper thighs also with reddened and welt areas (left 2" X 1/2", 2 1/2" X 3" and right thigh 2" X 1", 2 1/2" X 3"). Treated with Decadron 2mg IM and Orapred prescription. On 5/23/02, rash/hives fading.
I had flu like symptoms. I was very tired. I was dizzy and had loss of appetite. The reason why I went to the doctor was because it was carrying on a long time. He suggested that it might have been long COVID-19 that I had. I did take a home COVID-19 test that came back positive. Between 30 to 40 days later I'm still having the same symptoms. In all I have taken about three tests between December and February. I saw my primary care physician in January and my blood sugar was elevated for no reason. I haven't felt like myself since I had that last shot.
10 days following vaccination, patient experienced dizziness and lightheadedness. Continues to have dizziness/lightheadedness, more prevalent with stimulation, for example cooking while watching television.
pericarditis; block-head; body aches; fever; tiredness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERICARDITIS (pericarditis) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure increased (high blood pressure) since 2000 and Arthritis rheumatoid (rheumatory arth) since 1999. Concurrent medical conditions included Seafood allergy (lobster) and Seafood allergy (Crab). Concomitant products included QUINAPRIL and AMLODIPINE for Blood pressure abnormal, IBUPROFEN and METHOTREXATE for Rheumatoid arthritis, FOLIC ACID for an unknown indication.   On 26-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021 at 12:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced MENTAL IMPAIRMENT (block-head), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (tiredness). On 10-Apr-2021, the patient experienced PERICARDITIS (pericarditis) (seriousness criterion hospitalization). On 25-Feb-2021, MENTAL IMPAIRMENT (block-head), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (tiredness) had resolved. At the time of the report, PERICARDITIS (pericarditis) had resolved.            No treatment related information has been reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Per parent history, pt developed a tactile fever the evening after booster shots were given. Did not check temperature. Pt had a 2-3 minute episode of eyes rolling back in her head and trembling. Parents did not seek medical attention until next AM when they brought child to Peds visit.
Unable to feel heart beating in chest, even after heavy exertion. Same thing happened after first dose, but only lasted 3 weeks. I?m able to visualize my heart rate through  an application on my Watch, but do not physically feel  tasked, when performing exercises that push my  heart rate of over 140 bpm.
Severe back pain in thoracic and lumbar regions beginning on 12/24/20.  Arm pain lasting 2 days post injection.  Lymph node swelling and pain in axillary area beginning on 12/28/20.
Noticed pain, swelling and tightness in right arm. Site red, hot to touch with raised wheal measuring approx. 6-8 inches. Itching noted around edges of wheal.
Headache, body aches, low grade fever, fatigue, sore arm (like someone punched me in the arm)
per Wife; Patient was driven home, felt lethargic, went to bed early, around 6. in the Morning, Patient was having facial pain. Was seen by dentist on Saturday, returned a few days later, both Dr.'s evaluated patient. Was seen by a third Dentist. Since then, pain has been in face and jaw. Slightly sore and swollen at injection site. Pain caused patients blood pressure to rise.  Per Dr. after visit: Left facial painonset morning after vaccine. Dental etiology excluded. Clinical features consistent with trigeminal neuralgia
"COVID Arm" developed 9 Days after initial dose at injection site. Hypersensitivity skin reaction.
Patient received the vaccination around 12:05 PM on October 11, 2018. After 2-3 hours the patient started feeling a general malaise, swelling under the right arm, fever and chills. By 7:00 PM, on October 11, 2018, the patient states that she experienced a fever of 101 degrees Fahrenheit. At this point, the patient began taking Ibuprofen to help with the pain and Acetaminophen to help with the fever. Patient has been seen by the pharmacist, and has been advised to continue NSAID use to control the symptoms, to apply heat at the site, and to document any changes in fever or pain. Patient has been advised by the pharmacist that the normal course of adverse reaction is less than 72 hours, patient has been given information explaining the adverse reaction that she is experiencing. Patient has also been informed of being entered into VAERS, due to the adverse reaction that she has experienced.
Awake, Thurday a.m., 7/30/09, with scattered red itchy rash all over body. Pt. taken to clinic and given a steroid shot for allergic reaction to something by CRNP.
SEVERE PAIN AND BURNING. RASH APPROXIMATELY 2INCHES WIDE AND 5 INCHES LONG.  STARTING ABOUT 11 AM THIS MORNING AND AFTER ICING IT CHANGED AND WAS MORE APPARENT. WENT FROM LIGHT RED TO DARK RED AND PURPLE
My left eye turned red. I went to the doctor on 12/21, 12/23 it was not better. I woke up in tears because it was so painful. I went to the doctor again, they said it looked like inflammation of the iris. On 12/26 is saw an eye doctor that said it was episquaritis. I had a follow up appointment on 01/11 with the eye doctor he found out I have nodular degeneration. I had a follow up on 01/25 and was referred to a cornea specialists. This all started post vaccine. I have not history of eye problems.
I see my doctor every 6 months and I went to a regular doctor?s appointment and I developed high blood pressure. They gave me some medications. I am still taking those pills. They did a blood test and urine test, but I do not know the results.
The first vaccine, I experienced chills in the early evening first, then fever overnight. Was lethargic for approx. a week.; The first vaccine, I experienced chills in the early evening first, then fever overnight. Was lethargic for approx. a week.; The first vaccine, I experienced chills in the early evening first, then fever overnight. Was lethargic for approx. a week.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received bnt162b2 (Pfizer/BionTech COVID 19 brand), dose 1 via an unspecified route of administration, administered in left arm on 01Apr2021 16:00 (Lot Number: ER8734) as single for COVID-19 immunization. Medical history included allergies, obesity, and exercise-induced asthma (diagnosed) from an unknown date and unknown if ongoing. Concomitant medications included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported; chlorpheniramine maleate taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took codeine and experienced sensitive to codeine product. After the first vaccine on 01Apr2021, patient experienced chills in the early evening first, then fever overnight on 01Apr2021. The patient was lethargic for approx. a week from Apr2021. Outcome of events was recovered in Apr2021. Events was reported as non-serious. The patient has received 2nd dose (lot # ER8736) on 29Apr2021 18:00 in the left arm.  Follow-up attempts are needed. Further information is requested.
fatigue; general ickyness off; This is a spontaneous report from a non-contactable physician (patient herself). A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunization. Medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date (December or January) for covid-19 immunization. On an unspecified date, the patient experienced fatigue and general ickyness off. She indicated that it was a good sign her immune system was working. The outcome of the events was unknown.   No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
This spontaneous report was received from two physicians via a company representative referring to an approximately 18 year old (reported as college age, around 18 years old) patient (unspecified gender). The patient's medical history and concurrent conditions were not provided. On unspecified dates, the patient was vaccinated with two doses off (Oka/Merck) VARIVAX (doses, lot numbers and expiration dates not reported). Both doses for prophylaxis. Concomitant therapies were not provided. On an unknown date, the patient had titers drawn which were negative for immunity to varicella (antibody test negative). The outcome of antibody test negative was unknown. There was no product quality complaint (PQC) reported. This is one of several reports from the same source. Additional information has been requested.
Information has been received from a nurse concerning a female with no pertinent medical history or prior drug reactions/ allergies who on 08-JUN-2007 was vaccinated with the first dose of Gardasil (lot #653735/0668F), 0.5ml intramuscularly. The patient's last menstrual period occurred during the last week of June 2007. On 09-AUG-2007 the patient received her second dose of Gardasil (lot# 655617/1447F). On 01-NOV-2007 the patient reported that "recent" laboratory test included a pregnancy test with a negative result. No other symptoms were reported. Unspecified medical attention was sought. Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/14/2007. Initial and follow up information have been received from a nurse concerning a black female with no pertinent medical history or prior drug reactions / allergies who on 08-JUN-2007 was vaccinated with the first dose of GARDASIL (lot # 653735/0688F), 0.5mL Intramuscularly. The patient's last menstrual period occurred on 28-MAY-2007. On 09-AUG-2007 the patient received her second dose of GARDASIL (lot# 655617/1447F). It was reported that from approximately the beginning of July the patient "felt like she was going to get her menses, experiencing cramps and nausea." On 01-NOV-2007 the patient was seen by her physician and reported that "recent" laboratory test included a pregnancy test with a negative result. No other symptoms were reported. On 18-DEC-2007 the patient was seen by her OBGYN and reported that she had her menses (date not provided). On 18-DEC-2007 the patienet received her third vaccination of GARDASIL (lot# not provided). Additional information has been requested.
2 episodes of brief tonic-clonic sz @ 2 & 6AM today;had wnd DTP day a/;
Heart attack within 30 hours on 12/22/2021; went to ER at Hospital: on 12/27/2021 an angiogram was performed and a stent was placed at LAD due to 70% blockage...
I started having headaches in lower part of my head that radiated into my neck. It felt like a nerve spasm that was very painful. I made an appointment with my doctor when the headaches would not go away after a few days. My doctor ordered a CT scan, that did not reveal anything. My doctor prescribed Tramadol and Metaxalone to help with the pain. Today is the first day I have not had any pain.
Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 21Feb2021 at 10:30 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia and allergic to lobster. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), eicosapentaenoic acid ethyl ester (VASCEPA) and metformin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient  received unspecified vaccines within four weeks prior to the vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Jan2021 at 14:15 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. On 01Feb2021, the patient underwent COVID test via nasal swab and the result was negative. On 24Feb2021 at 06:00, the patient experienced dizziness which had not started until 3 days after the vaccination and persisted for 3 days so far. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient was tested for COVID-19. Therapeutic measures were not taken as a result of the events reported. The clinical outcome of the event dizziness was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt received Tetanus & ZOSTAVAX on 5/16. Noticed pain & erythema 2 days later at site of ZOSTAVAX & warmth & itching. Erythema spreading. No fever. Dx cellulitis. Area marked. Given KEFLEX 500mg BID x 7 days. CLARITIN or BENADRYL for itching. F/U in 4 days. Sooner if worsening.
I woke up at 03:00AM with severe stomach cramps. I started experiencing severe diarrhea and vomiting. At about 09:30AM, my parents took me to the emergency room. Upon arrival, I was tested for flu and COVID-19. Both tests came back negative. They gave me an IV with fluids and took some blood. The doctor ordered a CT scan of my abdomen and an ECG. The CT scan showed a lot of fluid in my intestinal tract. The doctor diagnosed me with an Upper GI Viral Infection. My rheumatoid arthritis was very inflamed. They gave me an injection of morphine and vallum. They also gave me an injection of ZOFRAN for the nausea. When I left, I was no longer vomiting or experiencing diarrhea. That evening, I felt a lot better, but I was weak. My lips were cracked from dehydration and my throat was so raw I couldn't talk. I followed up with my Primary Care Physician at my regular appointment on December 14, 2022. He said the blood work came back normal.
patient had a seizure the night of the vaccination with moderna bivalent booster and flu shot. Has hx of seizures, but has not had a seizure for about a year before this one.
high fever; vomiting; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. A 16-year-old male patient received 1st dose of meningococcal group b rlp2086 (TRUMENBA) with meningococcal vaccine a/c/y/w; both via unspecified routes of administration on an unspecified date at  single doses for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced high fever and vomiting on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
patient had syncopal episode for 5 to 10 seconds after administration then came to. reports having anxiety with needles and feeling lightheaded with other shots but this was the first instance reporting passed out.
BODY ACHE; ARMPIT PAIN; ARMPIT SWELLING; CHILLS; NAUSEA; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight was 150 pounds, and height was 168 centimeters. The patient's concurrent conditions included alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies, drug abuse/illicit drug use. the patient was not pregnant at the time of reporting. no pertinent medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 203A21A, and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 13-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAY-2021, the subject experienced body ache. On 14-MAY-2021, the subject experienced armpit pain. On 14-MAY-2021, the subject experienced armpit swelling. On 14-MAY-2021, the subject experienced chills. On 14-MAY-2021, the subject experienced nausea. On 14-MAY-2021, the subject experienced headache. On 14-MAY-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99.8 degree F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, chills, nausea, headache, and fever on 14-MAY-2021, and was recovering from armpit pain, and armpit swelling. This report was non-serious.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient passed out and came to quickly.  Monitored him for about an hour.
Gave the Moderna Bivalent vaccine after 2 months from the last Moderna Bivalent vaccine. No adverse effects reported from patient.
Fever 104 and screaming episode lasting appproximately 3 hrs following DTP/OPV immunization.
On 1/11/23 (1 day after vaccines), patient developed large area of redness and swelling in left arm along with pain . Mom advised to treat with compresses and give tylenol and advil for pain. Mom notes on 1/13/23 symptoms improving. Mom states symptoms took 1 week to resolve in total
Information has been received from a consumer concerning her 84 year old husband who on 30-NOV-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (lot 655291/0985F).  On 30-NOV-2006, the patient developed cellulitis.  The patient sought unspecified medical attention.  At the time of this report, the patient was recovering.  Additional information has been requested.
Received flu vaccine at 2:00 PM on 10/14/21. Then developed mastitis overnight on 10/14/21 with breast pain and red spot, low grade fever, chills, headache and body aches. Was prescribed Dicloxacillin after phone call to OBGYN and started 500mg QID on 10/15/21 at 7:00pm. Symptoms resolved by 10/16/21 at 7:00am.
11days p/vax pt became cranky, & devel small red dots on body. MD described condition as a rash.
With 48 hrs of immunization, infant began twitching her rt arm and was irritable, temp 101.
Reaction occurred seven days after the initial vaccine. Severe redness, swelling, burning, hot sensation approximately 5 inches in diameter around the injection site.
Pt states approximately 45 minutes after vaccination that she developed a rash on her chest and her throat felt itchy. Pt called clinic and was advised by MD to take Benadryl and go immediately to the ER if she developed any SOB. Patient called at 1:30 PM and states after taking Benadryl her symptoms resolved.
IRRITATION AT INJECTION SITE; UNCOMFORTABLE; PAIN DURING INJECTION; VERY SORE MUSCLE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced irritation at injection site, uncomfortable, pain during injection, and very sore muscle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain during injection, irritation at injection site, uncomfortable and very sore muscle was not reported. This report was non-serious.
Patient in for 4 mo wcc. When time to receive vaccinations pt was shown to be given wrong vaccine at 2 mo wcc. Mom notified pt missed a vaccine at 2 mo wcc on 7/23/08.
Pt. came in this morning to get Kindergarten immunizations and a flu shot.  He rec'd DTaP, IPV, MMR, Varivax and a flu shot.  Approx 5 minutes after getting immunizations, he began to c/o to parents of difficulty breathing.  When staff returned to the room, he was upright and presented with increased resp rate & effort and wheezing.  Decreased aeration throughout all lung fields.  Dr. arrived in room and ordered Epi 0.3 mg sub Q (given in R anterior thigh) and Albuterol nebulizer 2.5 mg/3 ml NaCl.  Pulse ox at that time was 85-88% on RA.  Started O2 at 1/2 L/NP.  Pulse ox improved to 90%.  Improved aeration throughout but still wheezing.  Increased O2 to 1 L/NP.  EMS notified and arrived at approx. 0940.  Resp effort improved and was able to talk briefly.  Still wheezing.  Pulse ox steady at 93-94% on 1 L O2/NP.  BP 116/58 with HR of 123 after Albuterol Neb.  Assisted onto stretcher and transported to ER for further stabilization and treatment.
Allergic reaction; Red blotches nose, spots inside hands/ some rashes inside hands, skin, inside hands like little dots, snow white dots surrounding red rashes, like hundreds of them white little circle dots; head rashes/nose  too high to low, lowdots on nose rashes like rashes and on nose but they come and go and they went away but these look like buyers spots in my hands; This is a spontaneous report received from a contactable consumer.  A male patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02May2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date for Covid-19 immunisation (first dose, rash). On unknown date, the patient experienced allergic reaction. On unknown date the patient experienced red blotches on nose and spots inside his hands/ the patient had some rashes inside hands, skin, on inside hands like little dots, snow white dots surrounding red rashes or something they was like hundreds of them white little circle dots (they sometime were more, sometimes they went away, then they came back, they went away). On unknown date, the patient experienced head rashes/ nose too high to low, low dots on nose rashes like rashes and on nose but they came and went ,and they went away but these look like buyers spots in hands. The outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Extreme chills then 101 fever, started about 11 pm.  Woke in morning still had the fever, then took Tylenol and by 5 pm felt better, fever gone.
8:00 PM CHILLS AND SEVERE HEADACHE LASTING 5 HOURS.
7cm erythema, tender lt arm; p/inject feeling lightheaded, loss of memory, fainting spells;
PNEUMOVAX given 1/20/2012, immed onset - malaise & fever for 2-3 d: swelling & 6 x 4 cm hematoma at inj site. Redness extended to just below axilla & down to elbow.
"aching, Knot," describing area where  immunization was given. "sore today  per employee.